Swedish Biotech Stock News

OM:RVRC
OM:RVRCSpecialty Retail

European Market: 3 Stocks Conceivably Trading Below Estimated Value

The European market has recently faced renewed trade and geopolitical uncertainties, leading to a decline in major stock indexes such as the STOXX Europe 600, France's CAC 40, and Germany's DAX. Despite these challenges, business activity in the eurozone remains positive with increased optimism about future growth prospects. In this environment, identifying potentially undervalued stocks requires a focus on companies that demonstrate strong fundamentals and resilience amidst broader market...
OM:ELAN B
OM:ELAN BLogistics

Elanders (OM:ELAN B) Returns To Quarterly Profit Challenging Ongoing Loss Narrative

Elanders (OM:ELAN B) closed out FY 2025 with Q4 revenue of SEK 3,053 million and basic EPS of SEK 1.27, alongside trailing twelve month revenue of SEK 12,201 million and a trailing EPS loss of SEK 1.53. Over recent quarters, revenue has moved between SEK 2,872 million and SEK 3,774 million, while quarterly EPS has ranged from a loss of SEK 2.40 to a profit of SEK 5.26. This gives investors a clear view of how earnings have swung around a relatively stable top line. With forecasts pointing to...
OM:HPOL B
OM:HPOL BChemicals

Assessing HEXPOL (OM:HPOL B) Valuation After Weaker 2025 Results And Recent Share Price Reaction

HEXPOL (OM:HPOL B) reported full year 2025 results with sales of SEK 19,324 million and net income of SEK 1,943 million, both lower than the prior year. This has set the backdrop for recent share performance. See our latest analysis for HEXPOL. The 1-day share price return of 13.87% following the weaker 2025 results adds to a 17.74% 30-day and 17.50% year to date share price decline, while the 1-year total shareholder return of 27.85% indicates pressure building over both shorter and longer...